Analysis of the tumor suppressor gene p16((INK4A), in microdissected melanoma metastases by sequencing, and microsatellite and methylation screening

Archives of Dermatological Research

Volumn 291, Issue 7-8, 1999, Pages 474-477

  Von Eggeling, Ferdinand ^a   Werner, Gregor ^a   Theuer, Claudia ^a   Riese, Ulrike ^a   Dahse, Regine ^a   Fiedler, Wolfgang ^a   Schimmel, Bettina ^a   Ernst, Günther ^a   Karte, Kerstin ^a   Claussen, Uwe ^a   Wollina, Uwe ^a  

^a JENA UNIVERSITY HOSPITAL   (Germany)

Author keywords

Loss of heterozygosity; Melanoma; Methylation; Mutation; p16

Indexed keywords

ARTICLE; CANCER MORTALITY; CELL CYCLE; CHROMOSOME 9P; GENE MUTATION; GENE SEQUENCE; HETEROZYGOSITY LOSS; HUMAN; HUMAN CELL; HUMAN TISSUE; LYMPH NODE METASTASIS; MELANOMA; METASTASIS; METHYLATION; MICROSATELLITE INSTABILITY; PRIORITY JOURNAL; PROGNOSIS; RECURRENCE RISK; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; TUMOR SUPPRESSOR GENE;

DISSECTION; DNA; DNA METHYLATION; DNA MUTATIONAL ANALYSIS; GENES, P16; HUMANS; LOSS OF HETEROZYGOSITY; MELANOMA; MICROSATELLITE REPEATS; SKIN NEOPLASMS;

EID: 0032823069     PISSN: 03403696     EISSN: None     Source Type: Journal    
DOI: 10.1007/s004030050440     Document Type: Article

References (33)

1. Chang AE, Karnell LH, Menck HR (1998) The National Cancer Database report on cutaneous and noncutaneous melanoma: a summary of 84,836 cases from the past decade. The American College of Surgeons Commission on Cancer and the American Cancer Society. Cancer 15:1664-1678
2. El Naggar AK, Lai SL, dayman G, Lee JKJ, Luna MA, Goepfert H, Batsakis JG (1997) Methylation, a major mechanism of p16/CDKN2 gene inactivation in head and neck squamous carcinoma. Am J Pathol 151:1767-1774
3. Flores JF, Walker GJ, Glendening JM, Haluska FG, Castresana JS, Rubio MP, Pastorfide GC, Boyer LA, Kao WH, Bulyk ML, Barnhill RL, Hayward NK, Housman DE, Fountain JW (1996) Loss of the p16INK4a and p15INK4b genes, as well as neighboring 9p21 markers, in sporadic melanoma. Cancer Res 56: 5023-5032
4. Foulkes WD, Flanders TY, Pollock PM, Hayward NK (1997) The CDKN2A (p16) gene and human cancer. Mol Med 3:5-20
5. Funk JO, Schiller PI, Barrett MT, Wong DJ, Kind P, Sander CA (1998) p16(INK4a) expression is frequently decreased and associated with 9p21 loss of heterozygosity in sporadic melanoma. J Cutan Pathol 25:291-296
6. Gonzalez Zulueta M, Bender CM, Yang AS, Nguyen T, Beart RW, Van Turnout JM, Jones PA (1995) Methylation of the 5′ CpG island of the p16/CDKN2 tumor suppressor gene in normal and transformed human tissues correlates with gene silencing. Cancer Res 55:4531-4535
7. Gonzalgo ML, Bender CM, You EH, Glendening JM, Flores JF, Walker GJ, Hayward NK, Jones PA, Fountain JW (1997) Low frequency of p16/CDKN2A methylation in sporadic melanoma: comparative approaches for methylation analysis of primary tumors. Cancer Res 57:5336-5347
8. Greene MH (1997) Genetics of cutaneous melanoma and nevi. Mayo Clin Proc 72:467-474
9. Haffner AC, Garbe C, Burg G, Buttner P, Orfanos CE, Rassner G (1992) The prognosis of primary and metastising melanoma. An evaluation of the TNM classification in 2,495 patients. Br J Cancer 66:856-861
10. Hayward NK (1996) The current situation with regard to human melanoma and genetic inferences. Curr Opin Oncol 8: 136-142
11. Herman JG, Graff JR, Myohanen S, Nelkin BD, Baylin SB (1996) Methylation-specific PCR: a novel PCR assay for methylation status of CpG islands. Proc Natl Acad Sci U S A 93:9821-9826
12. Hussussian CJ, Struewing JP, Goldstein AM, Higgins PA, Ally DS, Sheahan MD, Clark WH Jr, Tucker MA, Dracopoli NC (1994) Germline p16 mutations in familial melanoma. Nat Genet 8:15-21
13. Kamb A, Shattuck Eidens D, Eeles R, Liu Q, Gruis NA, Ding W, Hussey C, Tran T, Miki Y, Weaver Feldbaus J, et al (1994) Analysis of the p16 gene (CDKN2) as a candidate for the chromosome 9p melanoma susceptibility locus. Nat Genet 8:23-26
14. Keilholz U (1998) New prognostic factors in melanoma: mRNA tumour markers. Eur J Cancer 34 [Suppl 3]:S37-S41
15. Kumar R, Sauroja I, Punnonen K, Jansen C, Hemminki K (1998) Selective deletion of exon 1 beta of the p19(ARF) gene in metastatic melanoma cell lines. Genes Chromosomes Cancer 23:273-277
16. Liggett WH, Sidransky D (1998) Role of the p16 tumor suppressor gene in cancer. J Clin Oncol 16:1197-1206
17. Little M, Wainwright B (1995) Methylation and p16: suppressing the suppressor. Nat Med 1:633-634
18. Merlo A, Herman JG, Mao L, Lee DJ, Gabrielson E, Burger PC, Baylin SB, Sidransky D (1995) 5 CpG island methylation is associated with transcriptional silencing of the tumour suppressor p16/CDKN2/MTS1 in human cancers. Nat Med 1: 686-692
19. Ohta M, Berd D, Shimizu M, Nagai H, Cotticelli M, Mastrangelo M, Shields JA, Shields CL, Croce CM, Huebner K (1996) Deletion mapping of chromosome region 9p21-p22 surrounding the CDKN2 locus in melanoma. Int J Cancer 65: 762-767
20. Park WS, Vortmeyer AO, Pack S, Duray PH, Boni R, AliGuerami A, EmmertBuck MR, Liotta LA, Zhuang ZP (1998) Allelic deletion at chromosome 9p21(p16) and 17p13(p53) in microdissected sporadic dysplastic nevus. Hum Pathol 29:127-130
21. Piccinin S, Doglioni C, Maestro R, Vukosavljevic T, Gasparotto D, D'Orazi C, Boiocchi M (1997) p16/CDKN2 and CDK4 gene mutations in sporadic melanoma development and progression. Int J Cancer 74:26-30
22. Prives C (1998) Signaling to p53: breaking the MDM2-p53 circuit. Cell 95:5-8
23. Quelle DE, Zindy F, Ashmun RA, Sherr CJ (1995) Alternative reading frames of the INK4a tumor suppressor gene encode two unrelated proteins capable of inducing cell cycle arrest. Cell 83:993-1000
24. Reed JA, Loganzo F Jr, Shea CR, Walker GJ, Flores JF, Glendening JM, Bogdany JK, Shiel MJ, Haluska FG, Fountain JW, et al (1995) Loss of expression of the p16/cyclin-dependent kinase inhibitor 2 tumor suppressor gene in melanocytic lesions correlates with invasive stage of tumor progression. Cancer Res 55:2713-2718
25. Robertson KD, Jones PA (1998) The human ARF cell cycle regulatory gene promoter is a CpG island which can be silenced by DNA methylation and down-regulated by wild-type p53. Mol Cell Biol 18:6457-6473
26. Serrano M, Hannon GJ, Beach D (1993) A new regulatory motif in cell-cycle control causing specific inhibition of cyclin D/CDK4. Nature 366:704-707
27. Serrano M, Lee H, Chin L, Cordon Cardo C, Beach D, De-Pinho RA (1996) Role of the INK4a locus in tumor suppression and cell mortality. Cell 85:27-37
28. Stone S, Jiang P, Dayananth P, Tavtigian SV, Katcher H, Parry D, Peters G, Kamb A (1995) Complex structure and regulation of the P16 (MTS1) locus. Cancer Res 55:2988-2994
29. Talve L, Sauroja I, Collan Y, Punnonen K, Ekfors T (1997) Loss of expression of the p16INK4/CDKN2 gene in cutaneous malignant melanoma correlates with tumor cell proliferation and invasive stage. Int J Cancer 74:255-259
30. Thibodeau SN, Bren G, Schaid D (1993) Microsatellite instability in cancer of the proximal colon. Science 260:816-819
31. Reference deleted
32. Wagner SN, Wagner C, Briedigkeit L, Goos M (1998) Homozygous deletion of the p16(INK4a) and the p15(INK4b) tumour suppressor genes in a subset of human sporadic cutaneous malignant melanoma. Br J Dermatol 138:13-21
33. Zhang YP, Xiong Y, Yarbrough WG (1998) ARF promotes MDM2 degradation and stabilizes p53: ARF-INK4a locus deletion impairs both the Rb and p53 tumor suppression pathways. Cell 92:725-734